VRDNViridian Therapeutics, Inc.\DEvs its industry peers
A metric-by-metric comparison of Viridian Therapeutics, Inc.\DE against SIC 2834 — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| Empresa | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| VRDNEsta | $2.8B#3 | — | 4.3x#2 | 40.2x#4 | 23359.9%#1 | -26.9%#7 | -512.9%#4 | -51.7%#4 | -54.5%#4 | — | 8.6%#3 | — |
| AMLX | $3.3B#1 | — | 13.6x#6 | — | -100.0%#6 | 52.0%#3 | — | -60.5%#5 | — | — | — | — |
| BHC | $3.0B#2 | — | — | 0.3x#1 | 6.7%#3 | 441.3%#1 | 17.7%#2 | — | 3.7%#2 | — | — | 11.7%#1 |
| BHVN | $2.4B#4 | — | — | — | — | 12.7%#5 | — | — | — | — | 5.1%#4 | — |
| PBH | $2.3B#5 | 13.9x#1 | 1.2x#1 | 2.2x#2 | -4.3%#4 | -11.3%#6 | 28.4%#1 | 9.9%#1 | 5.9%#1 | 4#1 | -18.2%#5 | — |
| IMNM | $2.3B#6 | — | 4.4x#3 | 332.7x#5 | -23.2%#5 | 27.5%#4 | -3228.8%#5 | -40.4%#3 | -72.8%#6 | — | — | — |
| XNCR | $2.3B#7 | — | 4.5x#4 | 18.2x#3 | 13.7%#2 | 60.5%#2 | -141.4%#3 | -18.3%#2 | -31.5%#3 | — | 120.4%#1 | — |
| VERA | $2.2B#8 | — | 5.4x#5 | — | — | -96.9%#8 | — | -73.5%#6 | -72.7%#5 | — | 18.5%#2 | — |
Peer set: US filers sharing this company's SEC industry classification (SIC 2834). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. Esta tabla agotó el tiempo durante su construcción, por lo que cubre parte del grupo; los rangos son solo dentro de las filas mostradas y se completará en breve. Table built 2026-11-04.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice